首页 > 市场调查报告书 > 製药

非专利药糖尿病生物製剂生技仿製药

市场调查报告书

商品编码

1391920

基础胰岛素市场：按类型、输送装置、适应症、年龄层、配销通路、地区

Basal Insulin Market, By Type, By Delivery Device, By Indication, By Age Group, By Distribution Channel, By Geography

出版日期: 2023年11月10日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

基础胰岛素市场规模预计将从 2023 年的 163 亿美元增加到 2030 年的 313 亿美元，预测期内复合年增长率为 9.8%。

报告范围		报告详情
基准年	2022年	2023年市场规模	163亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	9.80%	2030年市场规模预测	313亿美元

图 1. 2023 年基础胰岛素全球市场占有率(%)（按地区）

基础胰岛素是一种长效胰岛素，可在白天和夜间稳定释放胰岛素，以控製糖尿病患者的血糖值。它通常用于需要胰岛素治疗的 1 型或 2 型糖尿病患者。基础胰岛素可维持用餐之间和用餐期间稳定的血糖值，为最佳糖尿病管理奠定基础。

由于全球糖尿病盛行率不断上升，全球基础胰岛素市场正经历显着成长。根据国际糖尿病联盟的数据，到 2045 年，成人糖尿病患者人数预计将达到 7 亿人。糖尿病患者数量的增加刺激了对基础胰岛素的需求，而基础胰岛素是糖尿病管理的重要组成部分。

市场动态：

基础胰岛素市场由多种因素驱动。糖尿病（尤其是第 2 型糖尿病）盛行率的上升是市场的主要驱动因素。久坐的生活方式、不良的饮食习惯和肥胖等不健康的生活习惯导致全球糖尿病发生率不断上升。因此，对基础胰岛素的需求预计将显着增加。

此外，胰岛素治疗技术的进步也推动了市场的成长。具有改善的药物动力学特性的胰岛素类似物的开发显着提高了基础胰岛素治疗的功效和便利性。这些进步改善了血糖控制并降低了低血糖的风险。

例如，2023年10月23日，临床阶段的生物製药公司Adsia，其合作伙伴是总公司中国的製药公司通化东宝药业股份有限公司，宣布推出含有Insulin Lispro和Insulin Glargine的Chaperone组合。我们宣布了三个项目的积极结果对 THDB0207 製剂进行的临床试验。这三项研究显示 BC Combo 是一种有用的胰岛素，结合了长效和速效胰岛素的特性。从而确保餐后和空腹血糖控制。

然而，也存在阻碍基础胰岛素市场成长的因素。一些障碍包括胰岛素治疗的高昂费用以及某些地区获得医疗保健的机会有限。此外，胰岛素生产和分销的严格监管要求给市场参与者带来了挑战。

儘管有这些挑战，基础胰岛素市场仍存在一些成长机会。老年人口的增加和人们对糖尿病管理重要性的认识不断提高预计将推动市场成长。此外，智慧胰岛素输送系统的市场开拓以及数位技术在糖尿病管理中的整合为市场参与者提供了开拓的新途径。

本研究的主要特点

本报告对全球基础胰岛素市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它揭示了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
根据公司亮点、产品系列、主要亮点、财务实绩和策略对全球基础胰岛素市场的主要参与者进行了介绍。
该报告的见解使行销人员和负责人能够就未来的产品发布、产品类型升级、市场扩张和行销策略做出明智的资讯。
全球基础胰岛素市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球基础胰岛素市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 16.3 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	9.80%	2030 Value Projection:	US$ 31.3 Bn

Basal insulin is a type of long-acting insulin that provides a steady release of insulin throughout the day and night to control blood sugar levels in individuals with diabetes. It is typically prescribed for individuals with type 1 diabetes or type 2 diabetes who require insulin therapy. Basal insulin helps maintain stable blood sugar levels between meals and during periods of fasting, providing a foundation for optimal diabetes management.

The global basal insulin market is experiencing significant growth, driven by the increasing prevalence of diabetes worldwide. According to the International Diabetes Federation, the number of adults with diabetes is expected to reach 700 million by 2045. This rise in diabetes cases is fueling the demand for basal insulin, as it is an essential component of diabetes management.

Market Dynamics:

The basal insulin market is driven by several factors. The rising prevalence of diabetes, particularly type 2 diabetes, is a key driver for the market. Unhealthy lifestyle habits, such as sedentary behavior, poor diet, and obesity, are contributing to the increasing incidence of diabetes globally. As a result, the demand for basal insulin is expected to rise significantly.

In addition, advancements in insulin therapy technologies are also driving the market growth. The development of insulin analogs, which have improved pharmacokinetic properties, has significantly enhanced the efficacy and convenience of basal insulin therapy. These advancements have led to better glycemic control and reduced risks of hypoglycemia.

For instance, on October 23, 2023, Adocia, a biopharmaceutical company in the clinical stage, announced that Tonghua Dongbao Pharmaceutical Co. Ltd., a pharmaceutical company based in China, is its partner and has released positive results from three clinical studies conducted on the BioChaperone Combo THDB0207 formulation, which contains insulin lispro and insulin glargine. These three studies showed that BC Combo is a useful insulin that combines the qualities of both long-acting and rapid-acting insulin. As a result, it can guarantee glycemic control during the postprandial and fasting periods.

However, there are certain restraints that may hinder the growth of the basal insulin market. The high cost of insulin therapy and limited access to healthcare in certain regions are some of the barriers. Additionally, the stringent regulatory requirements for insulin production and distribution pose challenges for market players.

Despite these challenges, there are several opportunities for growth in the basal insulin market. The increasing geriatric population, as well as the growing awareness about the importance of diabetes management, are expected to drive the market growth. Furthermore, the development of smart insulin delivery systems and the integration of digital technologies in diabetes management present new avenues for market players to explore.

Key Features of the Study:

This report provides an in-depth analysis of the global basal insulin market including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key players in the global basal insulin market are profiled based on company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered in this study include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, Gan & Lee Pharmaceuticals, Tonghua Dongbao Pharmaceutical, United Laboratories, Merck, Wockhardt, Julphar Diabetes, Medtronic, Beta Bionics, Zealand Pharma, MannKind, Peptron, Dexcom, Senseonics, Medtrum Technologies, SOOIL Development, and Semma Therapeutics
Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, type upgrades, market expansion, and marketing tactics
The global basal insulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global basal insulin market

Basal Insulin Market Segmentation:

By Type
- Glargine
- Detemir
- Degludec
By Delivery Device
- Syringes
- Pens
- Pumps
- Others (Inhalers, Patches)
By Indication
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
By Age Group
- Pediatric
- Adults
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Basal Insulin Market:
- Novo Nordisk
- Sanofi
- Eli Lilly and Company
- Biocon
- Gan & Lee Pharmaceuticals
- Tonghua Dongbao Pharmaceutical
- United Laboratories
- Merck
- Wockhardt
- Julphar Diabetes
- Medtronic
- Beta Bionics
- Zealand Pharma
- MannKind
- Peptron
- Dexcom
- Senseonics
- Medtrum Technologies
- SOOIL Development
- Semma Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Basal Insulin Market, By Type
- Global Basal Insulin Market, By Delivery Device
- Global Basal Insulin Market, By Indication
- Global Basal Insulin Market, By Age Group
- Global Basal Insulin Market, By Distribution Channel
- Global Basal Insulin Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising prevalence of diabetes, particularly type 2 diabetes
- Restraints
High cost of insulin therapy
- Opportunities
Increasing geriatric population
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Basal Insulin Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Basal Insulin Market, By Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Glargine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Detemir
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Degludec
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Basal Insulin Market, By Delivery Device, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others (Inhalers, Patches)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Basal Insulin Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gestational Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Basal Insulin Market, By Age Group, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Basal Insulin Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Global Basal Insulin Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Device, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Device, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Device, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Device, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Device, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Device, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
Eli Lilly and Company
Biocon
Gan & Lee Pharmaceuticals
Tonghua Dongbao Pharmaceutical
United Laboratories
Merck
Wockhardt
Julphar Diabetes
Medtronic
Beta Bionics
Zealand Pharma
MannKind
Peptron
Dexcom
Senseonics
Medtrum Technologies
SOOIL Development
Semma Therapeutics
Analyst Views

12. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

基础胰岛素市场：按类型、输送装置、适应症、年龄层、配销通路、地区